Louise Bowman

Louise Bowman is Professor of Medicine and Clinical Trials at the Nuffield Department of Population Health, University of Oxford, and Co-director of the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU). She also serves as an Honorary Consultant in Lipidology at Oxford University Hospitals Trust, maintaining active clinical practice through specialist lipid clinics. Her academic career integrates population health research with clinical medicine.

Her qualifications include:

• Bachelor of Arts (BA)
• Bachelor of Medicine, Bachelor of Surgery (MBBS)
• Doctor of Medicine (MD)
• Fellow of the Royal College of Physicians (FRCP)

Professor Bowman specializes in cardiovascular disease within diabetes populations, lipidology, and clinical trials methodology. She leads major international trials including ORION-4 (15,000 participants assessing inclisiran for cardiovascular disease) and AMALFI (atrial fibrillation screening), building on prior work as Co-principal Investigator for ASCEND (15,000 diabetic patients) and REVEAL (30,000 high-risk individuals). Her research emphasizes cost-effective trial design and reliable translation of findings into clinical practice.

Her 2025 publications reveal consistent focus on cardiovascular-diabetes intersections, with innovative approaches to screening (atrial fibrillation, diabetic eye disease) and methodological refinements in trial execution. These works demonstrate strong NHS integration and pragmatic solutions for real-world healthcare challenges.

As Co-Course Director for the part-time MSc in Clinical Trials, she trains next-generation researchers in large-scale trial methodology. While specific grant details aren't provided, leadership of major international trials indicates substantial funding. She mentors through academic roles though formal student lists aren't published.

Bowman operates within the CTSU ecosystem at Nuffield Department of Population Health – part of Oxford's 40-year legacy in population health research employing over 900 staff. The unit specializes in observational epidemiology, randomized trials, and health services research across global settings.